OTCMKTS:IPIX - Innovation Pharmaceuticals News Headlines

$0.1470
-0.03 (-18.33 %)
(As of 07/24/2019 04:26 AM ET)
Today's Range
$0.14
Now: $0.1470
$0.19
50-Day Range
$0.1235
MA: $0.19
$0.25
52-Week Range
$0.07
Now: $0.1470
$0.60
Volume1.22 million shs
Average Volume514,044 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Innovation Pharmaceuticals (OTCMKTS IPIX) News Headlines

Source:
DateHeadline
Innovation Pharma up 58% on Brilacidin license dealInnovation Pharma up 58% on Brilacidin license deal
seekingalpha.com - July 22 at 5:38 PM
Over $24M in initial and milestone-based paymentsOver $24M in initial and milestone-based payments
www.globenewswire.com - July 22 at 10:14 AM
Innovation Pharmaceuticals Announces License Agreement with Alfasigma S.p.A. for the Development and Commercialization of Brilacidin in Ulcerative Proctitis/Ulcerative ProctosigmoiditisInnovation Pharmaceuticals Announces License Agreement with Alfasigma S.p.A. for the Development and Commercialization of Brilacidin in Ulcerative Proctitis/Ulcerative Proctosigmoiditis
finance.yahoo.com - July 22 at 10:14 AM
Innovation Pharmaceuticals Signs Agreement for Advanced Oral Tablet Technology in Treating Inflammatory Bowel DiseaseInnovation Pharmaceuticals Signs Agreement for Advanced Oral Tablet Technology in Treating Inflammatory Bowel Disease
finance.yahoo.com - June 6 at 10:05 AM
Innovation Pharmaceuticals to Attend 2019 BIO International Convention, June 3-6Innovation Pharmaceuticals to Attend 2019 BIO International Convention, June 3-6
finance.yahoo.com - May 29 at 9:49 AM
Innovation Pharmaceuticals At Digestive Disease Week Conference, Nears Selecting Drug Formulation Company to Prepare Oral Brilacidin for Targeted Delivery in Ulcerative ColitisInnovation Pharmaceuticals At Digestive Disease Week Conference, Nears Selecting Drug Formulation Company to Prepare Oral Brilacidin for Targeted Delivery in Ulcerative Colitis
finance.yahoo.com - May 21 at 5:56 PM
Innovation Pharmaceuticals Announces Non-Binding Term Sheet Signed with Global Pharmaceutical Company to Develop and Commercialize Brilacidin for the Treatment of Ulcerative Proctitis/Ulcerative ProctosigmoiditisInnovation Pharmaceuticals Announces Non-Binding Term Sheet Signed with Global Pharmaceutical Company to Develop and Commercialize Brilacidin for the Treatment of Ulcerative Proctitis/Ulcerative Proctosigmoiditis
finance.yahoo.com - May 16 at 11:31 AM
Innovation Pharmaceuticals Receives FDA End-of-Phase 2 Meeting MinutesInnovation Pharmaceuticals Receives FDA End-of-Phase 2 Meeting Minutes
finance.yahoo.com - May 1 at 9:41 AM
Innovation Pharmaceuticals - "JAMA" Article Reinforces Need for Novel Oral Mucositis Treatments in Supportive Cancer Care; Company progresses through first stage of review by European Medicines Agency (EMA) regarding Scientific Advice for planned Phase 3 ProgramInnovation Pharmaceuticals - "JAMA" Article Reinforces Need for Novel Oral Mucositis Treatments in Supportive Cancer Care; Company progresses through first stage of review by European Medicines Agency (EMA) regarding Scientific Advice for planned Phase 3 Program
finance.yahoo.com - April 23 at 9:50 AM
Innovation Pharmaceuticals Reports p53 Drug Candidate Therapeutic Potential Further Supported by Academic Research in Leukemias and in Combination with Cancer ImmunotherapiesInnovation Pharmaceuticals Reports p53 Drug Candidate Therapeutic Potential Further Supported by Academic Research in Leukemias and in Combination with Cancer Immunotherapies
finance.yahoo.com - April 16 at 10:57 AM
Innovation Pharmaceuticals Reports Enhancements in Manufacture of Brilacidin Phase 3 Drug SupplyInnovation Pharmaceuticals Reports Enhancements in Manufacture of Brilacidin Phase 3 Drug Supply
www.globenewswire.com - April 9 at 10:33 AM
Innovation Pharmaceuticals Reports Enhancements in Manufacture of Brilacidin Phase 3 Drug SupplyInnovation Pharmaceuticals Reports Enhancements in Manufacture of Brilacidin Phase 3 Drug Supply
finance.yahoo.com - April 9 at 10:33 AM
Innovation Pharmaceuticals European Subsidiary, IPIX Pharma Ltd., Granted Meeting with European Medicines Agency (EMA) to Discuss International Phase 3 Brilacidin Oral Mucositis ProgramInnovation Pharmaceuticals European Subsidiary, IPIX Pharma Ltd., Granted Meeting with European Medicines Agency (EMA) to Discuss International Phase 3 Brilacidin Oral Mucositis Program
finance.yahoo.com - March 28 at 10:11 AM
Innovation Pharmaceuticals Requesting European Medicines Agency (EMA) Input for International Phase 3 Brilacidin Oral Mucositis ProgramInnovation Pharmaceuticals Requesting European Medicines Agency (EMA) Input for International Phase 3 Brilacidin Oral Mucositis Program
finance.yahoo.com - March 15 at 10:26 AM
Innovation Pharmaceuticals Forms Irish Subsidiary to Facilitate International Development of Clinical PipelineInnovation Pharmaceuticals Forms Irish Subsidiary to Facilitate International Development of Clinical Pipeline
finance.yahoo.com - February 26 at 10:28 AM
Innovation Pharmaceuticals Receives New Patent for Compounds for Use in Treatment of Oral MucositisInnovation Pharmaceuticals Receives New Patent for Compounds for Use in Treatment of Oral Mucositis
finance.yahoo.com - February 19 at 10:19 AM
Innovation Pharmaceuticals Files Form 10-Q Quarterly ReportInnovation Pharmaceuticals Files Form 10-Q Quarterly Report
finance.yahoo.com - February 11 at 11:18 AM
Innovation Pharmaceuticals Establishing European Subsidiary; CEO Increases Equity Stake in IPIXInnovation Pharmaceuticals Establishing European Subsidiary; CEO Increases Equity Stake in IPIX
finance.yahoo.com - January 31 at 9:44 AM
Innovation Pharmaceuticals Announces Clinical Development Plans for Oral Brilacidin for Inflammatory Bowel DiseaseInnovation Pharmaceuticals Announces Clinical Development Plans for Oral Brilacidin for Inflammatory Bowel Disease
finance.yahoo.com - January 22 at 9:50 AM
Innovation Pharmaceuticals Completes Gastric Fluid Testing of Brilacidin Supporting Development of an Oral Dosage Form to Treat Inflammatory Bowel DiseaseInnovation Pharmaceuticals Completes Gastric Fluid Testing of Brilacidin Supporting Development of an Oral Dosage Form to Treat Inflammatory Bowel Disease
finance.yahoo.com - January 14 at 9:11 AM
Company to Approach European Medicines Agency for International Development GuidanceCompany to Approach European Medicines Agency for International Development Guidance
globenewswire.com - January 8 at 9:48 AM
Published Studies Confirm Cisplatin Remains Preferred Chemotherapy Component in Head and Neck Cancer Treatment; Innovation Pharmaceuticals on Target with Clinical Trials of Brilacidin for Preventing Severe Oral MucositisPublished Studies Confirm Cisplatin Remains Preferred Chemotherapy Component in Head and Neck Cancer Treatment; Innovation Pharmaceuticals on Target with Clinical Trials of Brilacidin for Preventing Severe Oral Mucositis
finance.yahoo.com - January 8 at 9:48 AM
Innovation Pharmaceuticals Receives New Brilacidin Patent, Further Expanding Intellectual Property EstateInnovation Pharmaceuticals Receives New Brilacidin Patent, Further Expanding Intellectual Property Estate
finance.yahoo.com - January 2 at 9:35 AM
Innovation Pharmaceuticals Completes End-of-Phase 2 Meeting with FDA; Brilacidin Oral Rinse to Advance Into Phase 3 Clinical Trials for Prevention of Severe Oral MucositisInnovation Pharmaceuticals Completes End-of-Phase 2 Meeting with FDA; Brilacidin Oral Rinse to Advance Into Phase 3 Clinical Trials for Prevention of Severe Oral Mucositis
finance.yahoo.com - December 17 at 9:48 AM
Innovation Pharmaceuticals Presenting Brilacidin for Inflammatory Bowel Disease at “IBD Innovate 2018” Conference Hosted by the Crohn’s & Colitis FoundationInnovation Pharmaceuticals Presenting Brilacidin for Inflammatory Bowel Disease at “IBD Innovate 2018” Conference Hosted by the Crohn’s & Colitis Foundation
finance.yahoo.com - November 13 at 9:16 AM
Innovation Pharmaceuticals Provides Corporate Update Highlighting Business Development and Clinical Pipeline PrioritiesInnovation Pharmaceuticals Provides Corporate Update Highlighting Business Development and Clinical Pipeline Priorities
finance.yahoo.com - November 9 at 9:52 AM
Innovation Pharmaceuticals Expands Brilacidin Patent PortfolioInnovation Pharmaceuticals Expands Brilacidin Patent Portfolio
finance.yahoo.com - November 1 at 9:24 AM
Innovation Pharmaceuticals (IPIX) Secures End-of-Phase 2 Meeting with FDA for Clinical Development Program of Brilacidin Oral RinseInnovation Pharmaceuticals (IPIX) Secures End-of-Phase 2 Meeting with FDA for Clinical Development Program of Brilacidin Oral Rinse
www.streetinsider.com - October 25 at 4:13 PM
Innovation Pharmaceuticals Granted End-of-Phase 2 MeetingInnovation Pharmaceuticals Granted End-of-Phase 2 Meeting
finance.yahoo.com - October 24 at 4:13 PM
Innovation Pharmaceuticals Provides Update on Kevetrin Program; Bridging Toxicology Efforts Aimed at Developing an Oral p53 Anti-Cancer Drug CandidateInnovation Pharmaceuticals Provides Update on Kevetrin Program; Bridging Toxicology Efforts Aimed at Developing an Oral p53 Anti-Cancer Drug Candidate
finance.yahoo.com - October 22 at 9:34 AM
Innovation Pharmaceuticals Brilacidin as a Novel Inhibitor of Phosphodiesterase 4 (PDE4) Supports its Potential to Treat Autoimmune and Inflammatory Diseases; Company Invited to Present at Upcoming Crohn’s & Colitis Foundation ConferenceInnovation Pharmaceuticals Brilacidin as a Novel Inhibitor of Phosphodiesterase 4 (PDE4) Supports its Potential to Treat Autoimmune and Inflammatory Diseases; Company Invited to Present at Upcoming Crohn’s & Colitis Foundation Conference
finance.yahoo.com - October 12 at 4:07 PM
Innovation Pharmaceuticals Secures Up to $10 Million in Additional Financing to Advance Clinical PipelineInnovation Pharmaceuticals Secures Up to $10 Million in Additional Financing to Advance Clinical Pipeline
finance.yahoo.com - October 9 at 9:21 AM
Innovation Pharmaceuticals Provides a Comparative Perspective on Brilacidin’s Potential to Unlock the Oral Mucositis Market: Pharma Industry Attacks Severe Pain and Suffering Due to Cancer TreatmentsInnovation Pharmaceuticals Provides a Comparative Perspective on Brilacidin’s Potential to Unlock the Oral Mucositis Market: Pharma Industry Attacks Severe Pain and Suffering Due to Cancer Treatments
finance.yahoo.com - September 24 at 9:42 AM
Innovation Pharmaceuticals Provides Corporate Update Highlighting Upcoming Milestones and EventsInnovation Pharmaceuticals Provides Corporate Update Highlighting Upcoming Milestones and Events
finance.yahoo.com - September 20 at 9:53 AM
Innovation Pharmaceuticals to Present Brilacidin for Inflammatory Bowel Disease at Inaugural “IBD Innovate 2018” Conference Hosted by the Crohn’s & Colitis FoundationInnovation Pharmaceuticals to Present Brilacidin for Inflammatory Bowel Disease at Inaugural “IBD Innovate 2018” Conference Hosted by the Crohn’s & Colitis Foundation
finance.yahoo.com - September 5 at 9:49 AM
Innovation Pharma inks deal with Corerx to formulate and package Brilacidin for oral mucositis in sachet formInnovation Pharma inks deal with Corerx to formulate and package Brilacidin for oral mucositis in sachet form
seekingalpha.com - July 17 at 9:13 AM
Innovation Pharmaceuticals Signs Drug Product Manufacturing Contract with CoreRx to Formulate and Package Brilacidin for Oral Mucositis in Sachet FormInnovation Pharmaceuticals Signs Drug Product Manufacturing Contract with CoreRx to Formulate and Package Brilacidin for Oral Mucositis in Sachet Form
finance.yahoo.com - July 17 at 9:13 AM
Innovation Pharmaceuticals Announces $7 million Milestone Funding Agreement with Aspire CapitalInnovation Pharmaceuticals Announces $7 million Milestone Funding Agreement with Aspire Capital
finance.yahoo.com - June 30 at 11:49 AM
ProPak Asia 2018 Returns with the Latest Innovations & Technologies for Processing and Packaging IndustriesProPak Asia 2018 Returns with the Latest Innovations & Technologies for Processing and Packaging Industries
www.prnewswire.com - June 7 at 11:48 PM
Display Week 2018, Worlds Leading Event for Electronic Display Innovation, Attracts Thousands of Display EnthusiastsDisplay Week 2018, World's Leading Event for Electronic Display Innovation, Attracts Thousands of Display Enthusiasts
www.prnewswire.com - June 7 at 10:54 AM
Press Conference of 2018 China Innovation and Entrepreneurship Fair held in Beijing SuccessfullyPress Conference of 2018 China Innovation and Entrepreneurship Fair held in Beijing Successfully
www.prnewswire.com - June 6 at 8:31 PM
Aqua Lung Celebrates 75 Years of Discovery, Innovation, and Conservation; 1943-2018Aqua Lung Celebrates 75 Years of Discovery, Innovation, and Conservation; 1943-2018
www.prnewswire.com - June 6 at 9:34 AM
ContentWriters Releases White Paper Detailing Marketing Industry Innovations in the Addiction Treatment IndustryContentWriters Releases White Paper Detailing Marketing Industry Innovations in the Addiction Treatment Industry
www.prnewswire.com - June 6 at 9:34 AM
The 4th annual China-US Innovation Competition hosted by the Entrepreneur FoundationThe 4th annual China-US Innovation Competition hosted by the Entrepreneur Foundation
www.prnewswire.com - June 6 at 3:19 AM
World Travel, Inc. Welcomes Rock Blanco As Chief Innovation OfficerWorld Travel, Inc. Welcomes Rock Blanco As Chief Innovation Officer
www.prnewswire.com - June 5 at 10:10 AM
Orasis Pharmaceuticals Closes $13 Million Series B FinancingOrasis Pharmaceuticals Closes $13 Million Series B Financing
feeds.benzinga.com - June 5 at 9:51 AM
Fresco Logic Launches Innovative F-One(TM) Multi-protocol Signal Aggregation TechnologyFresco Logic Launches Innovative F-One(TM) Multi-protocol Signal Aggregation Technology
www.prnewswire.com - June 4 at 9:15 PM
D-Link Wins Computex d&i Award 2018D-Link Wins Computex d&i Award 2018
www.prnewswire.com - June 4 at 9:15 PM
Elon Musk-funded XPRIZE Is One Step Closer To Ending Global IlliteracyElon Musk-funded XPRIZE Is One Step Closer To Ending Global Illiteracy
www.forbes.com - June 4 at 6:43 PM
Marriott Looks to Innovation for GrowthMarriott Looks to Innovation for Growth
www.fool.com - June 4 at 6:43 PM
This page was last updated on 7/24/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel